标题/作者	年份
Nonalcoholic fatty liver disease 2020: the state of the disease TG Cotter, M Rinella Gastroenterology 158 (7), 1851-1864	2020
Comparison of MAFLD and NAFLD diagnostic criteria in real world SU Lin, J Huang, M Wang, R Kumar, Y Liu, S Liu, Y Wu, X Wang, Y Zhu Liver international 40 (9), 2082-2089	2020
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes AF Godoy-Matos, WS Silva Júnior, CM Valerio Diabetology & metabolic syndrome 12 (1), 1-20	2020
Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78	2022
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD S Yamamura, M Eslam, T Kawaguchi, T Tsutsumi, D Nakano, ... Liver International 40 (12), 3018-3030	2020
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update CPG Panel, A Berzigotti, E Tsochatzis, J Boursier, L Castera, N Cazzagon, ... Journal of hepatology 75 (3), 659-689	2021
AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review R Loomba, JK Lim, H Patton, HB El-Serag Gastroenterology 158 (6), 1822-1830	2020
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD) K Cusi, S Isaacs, D Barb, R Basu, S Caprio, WT Garvey, S Kashyap, ... Endocrine Practice 28 (5), 528-562	2022
Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview S Marchisello, A Di Pino, R Scicali, F Urbano, S Piro, F Purrello, ... International journal of molecular sciences 20 (8), 1948	2019
MAFLD and risk of CKD DQ Sun, Y Jin, TY Wang, KI Zheng, RS Rios, HY Zhang, G Targher, ... Metabolism 115, 154433	2021
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management T Marjot, A Moolla, JF Cobbold, L Hodson, JW Tomlinson Endocrine reviews 41 (1), 66-117	2020
Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening R Lomonaco, E Godinez Leiva, F Bril, S Shrestha, L Mansour, J Budd, ... Diabetes Care 44 (2), 399-406	2021
Differential effects of selective-and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆ S Lefere, T Puengel, J Hundertmark, C Penners, AK Frank, A Guillot, ... Journal of hepatology 73 (4), 757-770	2020
Limitations of non-invasive tests for assessment of liver fibrosis K Patel, G Sebastiani JHEP Reports 2 (2), 100067	2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study SA Harrison, V Ratziu, J Boursier, S Francque, P Bedossa, Z Majd, ... The lancet Gastroenterology & hepatology 5 (11), 970-985	2020
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363	2021
Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population H Gellert‐Kristensen, TG Richardson, G Davey Smith, BG Nordestgaard, ... Hepatology 72 (3), 845-856	2020
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe JV Lazarus, M Ekstedt, G Marchesini, J Mullen, K Novak, JM Pericàs, ... Journal of hepatology 72 (1), 14-24	2020
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785	2021
The role of insulin resistance and diabetes in nonalcoholic fatty liver disease H Fujii, N Kawada, Japan Study Group of Nafld (JSG-NAFLD) International journal of molecular sciences 21 (11), 3863	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。